GlassScriptPhysician profile
Brian S Pavey
NPI 1447361373
$13,713.95
in general payments reported to CMS, 2019-2025
47 companies · $1,028 in 2025
The $1,028 reported for 2025 was more than what 78% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $498 · 2020: $315 · 2021: $787 · 2022: $998 · 2023: $1,073 · 2024: $9,016 · 2025: $1,028.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,550 · Food and Beverage: $3,491 · Travel and Lodging: $992 · Education: $83.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,550.00 |
| Food and Beverage | $3,491.11 |
| Travel and Lodging | $992.43 |
| Education | $83.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Akebia Therapeutics INC | $5,979.17 | 2019-2024 | Vafseo, Auryxia |
| Calliditas Therapeutics US INC. | $2,721.87 | 2022-2025 | Tarpeyo |
| Amgen INC. | $666.28 | 2019-2025 | Tavneos, Evenity, Prolia |
| Pfizer INC. | $660.87 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $439.83 | 2020-2025 | Farxiga, Fasenra, Lokelma |
| Abbvie INC. | $290.13 | 2021-2025 | |
| Lilly USA, LLC | $283.46 | 2020-2025 | Mounjaro, Zepbound, Trulicity |
| Novartis Pharmaceuticals Corporation | $256.16 | 2019-2025 | |
| Fresenius USA Marketing, INC. | $215.37 | 2019-2025 | Velphoro, Velphoro, Korsuva |
| Mallinckrodt Hospital Products INC. | $208.69 | 2022-2024 | Acthar |
| Otsuka America Pharmaceutical, INC. | $182.28 | 2019-2025 | Jynarque, Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $172.40 | 2021-2025 | |
| Genzyme Corporation | $161.07 | 2021-2025 | |
| Novo Nordisk INC | $133.36 | 2019-2025 | Ozempic, Rybelsus |
| Stryker Corporation | $113.13 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Pavey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.